Investor Presentation January CSE ticker: GW
|
|
- Daisy Mosley
- 5 years ago
- Views:
Transcription
1 Investor Presentation January 2019 CSE ticker: GW
2 2 NOTICE TO RECIPIENT This investment is suitable only for sophisticated investors for whom an investment does not constitute a complete investment program, who do not require immediate liquidity for their investment and who fully understand and are willing to assume the risks involved. An investment may be considered to involve a substantial degree of risk, and an investor could lose all or a substantial amount of his or her investment. This document is not an offer to sell (or solicitation of an offer to buy) any interest in the Company. These materials may not be used or relied upon for any purpose other than as specifically contemplated by a written agreement. The materials may not be circulated outside of the recipient s organization, publicly referred to, or disclosed, in whole or in part, without express written permission. This presentation does not purport to be all inclusive or contain all the information that a prospective investor may require to fully evaluate an investment in the contemplated transaction. Prospective investors should conduct their own thorough investigation and due diligence before making an investment. DISCLAIMER This Presentation contains forward-looking statements and forward-looking information. Often, but not always, forward-looking statements can be identified by the use of words or phrases or state that certain actions, events or results may, could, would, might or will be taken, occur or be achieved. Forward-looking statements involve known and unknown words such as plans, expects or does not expect, is expected, estimates, intends, anticipates or does not anticipate, or believes, or variations of such words and risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements and information. Examples of such statements include: (A) the financial forecast of the Company; (B) the intention to grow the business and operations of the Company; (C) anticipated timing for the availability of the Company s products to market and expected sale prices; (D) expected growth in the number of users of medical and recreational marijuana anticipated; and (E) the expansion of the Company s business into other revenue streams. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this Presentation. Such forward-looking statements are based on a number of assumptions which may prove to be incorrect, including, but not limited to: the ability of the Company to obtain necessary financing; the ability to complete a going public transaction; the ability to satisfy the requirements of a stock exchange; the economy generally; consumer interest in the products of the Company; competition; and anticipated and unanticipated costs. These forward-looking statements should not be relied upon as representing the Company s views as of any date subsequent to the date of this Presentation. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements and information contained in this Presentation are expressly qualified in their entirety by this cautionary statement. The forward-looking statements and information included in this Presentation are made as of the date of this Presentation and the Company assumes no obligation to update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation. CSE ticker: VGW
3 3 One of the largest premium cannabis extraction companies in North America and the first colab facilitating cannabis product development for licensed producers globally
4 THE VALENS ADVANTAGE 4 THE WORLD IS OUR MARKET Health Canada licensed (multiple), EU GMP certification pending, Hemp License pending, Nutraceutical License pending setting Valens up for every servicing and consumer product opportunity, globally. DEVELOPMENT Through one of our Dealer s Licenses we hold the ability to perform research and clinical trials to better understand Cannabis and it s benefits, and to lead the way in purposeful product offerings around the world. BIG PICTURE BRANDING The Valens brand is recognized for delivering the most science driven, responsibly tested, sustainably derived products and services in the market. INDUSTRY-BACKED The experience and reputation of the team at Valens speaks for itself. We are a preferred partner of Canopy and other reputable industry players. SEED TO SALE TRANSPARENCY AND CONTROL Different strains, compounds and growing techniques provide different desired effects in finished products. By controlling our supply from the source right through to processing, we re able to ensure our products qualities are maximized and always purpose-driven. PROPRIETARY PROCESSING Our processing methods have been customized to ensure that the end product does not lose the valuable complexity of compounds responsible for the spectrum of desired effects that are often lost in the refining process. PRODUCT FLEXIBILITY We have the ability to produce a wide variety of products, allowing Valens to capitalize on multiple markets from medical to recreational to preferential method of consumption.
5 VALENS AGRITECH LTD. Health Canada licensed cannabis extraction center Extraction center with cultivation and research capabilities Proprietary, customized cannabis extraction processes Ability to import and export wholesale cannabis products world-wide Third party cannabis product development One of the largest capacities to extract in Canada and growing 25,000 sq ft plant to facilitate additional extraction production EU GMP Certification pending for global export anywhere
6 VALENS LABS LTD. Health Canada licensed cannabis extraction center Health Canada Dealers Licensed for testing and analysis Leading edge research laboratory Service provider specializing in the testing of metals, residual solvents, pesticides, mold, terpenes and cannabinoid profile ISO accreditation, first lab to be accredited in Canada for a cannabis matrix Named a Center of Excellence in Plant Based Science by $115B medical instruments company Thermo Fischer Scientific Setting the domestic standard in Health Canada-required third party product verification as well as globally.
7 VALENS REVENUE STREAMS 7 EXTRACTION ABILITY TO CREATE CUSTOM, FLEXIBLE AGREEMENTS RESIN REFINED OIL WHITE LABEL Processing from flower to crude oil Processing from flower to oil ready for market PRODUCTS Processing and packaging of oil for market Fee for service Fee for service or Revenue share Revenue share OTHER REVENUE SOURCES Lab Testing Services Direct Sales Export Sales 3rd Party Research & Development Product Development
8 EXTRACTION: THE FOUNDATION OF OPPORTUNITY 8 EDIBLES Snack edibles Trail mix, protein bars, jerky, sweets, etc. Infused prepared meals Food additives Cooking oils, honey, peanut butter Just add cannabis beverage containers with cannabis oil preloaded in the top, just like the vitamin waters with the powder dispenser on top Drinks alcoholic or non-alcoholic Oral sprays OIL/TINCTURES High THC/CBD tinctures Vaporizer Cartridges and Pens Capsules Concentrates TOPICALS Balms/creams/salves Bath soaks/salts Skin care products Body sprays Lubricants Essential oils Sublingual patches Transdermal patches
9 SoRSE TECHNOLOGY 9 SōRSE emulsion technology surrounds oils, transforming the entire solution into water-compatible forms All of this means you can add cannabis to products including beverages without that "weed" taste or smell. BREAKTHROUGH ITEMS TO NOTE Shelf stable for over 180 days (not proven anywhere else) Zero cannabis taste, color or odor Provides effective, consistent dosing Lower dosage sufficient due to increase in bioavailability when consumed Faster onset and offset, making it the safer and more trusted edible option WHAT THIS MEANS FOR VALENS Value-add in our oil services process to provide clients with water-soluble cannabis ready for mixing in liquids by the client Powder product ready to go to market that consumers can mix with any liquid of their own Exclusive Canadian rights to all Tarukino beverages including the #1 selling cannabis beverage in Washington, three years in a row, Happy Apple Cider.
10 10 C U R R E N T N E G O T I A T I O N S F O R I N T E R N A T I O N A L O P P O R T U N I T I E S G L O B A L M A R K E T GLOBAL LEGAL MARIJUANA MARKET EXPECTED TO REACH BILLION USD BY REPORT BUYER, APRIL 2018 C A N A D A - R x R e c r e a t i o n a l G E R M A N Y - R x M A L T A - R x EUROPEAN MEDICAL AND RECRECATIONAL MARKETS EXPECTED TO GROW TO BILLION BY THE EUROPEAN CANNABIS REPORT, PROHIBITION PARTNERS J A M A I C A - R x AS OF JUNE 7, 2018, CANADA IS THE FIRST MEMBER OF THE G7 TO LEGALIZE CANNABIS FOR RECREATIONAL USE ACROSS THE COUNTRY COLO M B I A - R x B R A Z I L - R x P E R U - R x A U S T R A L I A - R x N E W Z E A L A N D - R x A C T I V E L Y P U R S U I N G I N T E R N A T I O N A L L I C E N S I N G & D I S T R I B U T I O N CSE ticker: VGW
11 11 STRATEGIC PARTNERSHIPS C H A P T E R T W O
12 INITIATING COVERAGE Altacorp Capital
13 MANAGEMENT 13 TYLER ROBSON CEO / DIRECTOR With 15+ years grassroots experience, Mr. Robson was Chief Operating Officer of the Company until taking the reins as Chief Executive Officer in May 2017, as well as remaining Director of Operations at Valens AgriTech Inc. CHRIS BUYSEN, MPAcc, CPA, CA CFO Mr. Buysen has over 15 years of diverse financial experience working as a senior financial executive with many public and private organizations in a wide range of industries including retail, pharmacy and consumer packaged goods. CHANTEL POPOFF VP In 2007, Ms. Popoff was appointed Director of Operations, then Director of Marketing for a fast-growing Western Canadian retail pharmacy chain. In 2013 she joined a natural health food company as Director of Marketing and was promoted to President in SCOTT YOUNG IR& BUSINESS DEVELOPMENT Mr. Young s focus at Valens is corporate finance initiatives. Mr. Young has spent the past 15 years working in the capital market sectors of Canada, the United States and Europe. QUINN SHISKIN HEAD OF PRODUCTION Mr. Shiskin s career emanates around production as a multi-ticketed Red Seal tradesman; where he worked in a variety of industries including mining, oil sands, LNG, pulp and paper, and in the construction industry. With these skills, he entered the extraction industry where he revolutionized the process along the way. EVERETT KNIGHT, CFA EVP OF STRATEGY/INVESTMENTS Mr. Knight has managed one of the only institutional investment mandates focused on the cannabis industry where he analyzed and toured hundreds of cannabis companies. His experience in the sector began in 2014 and since that time, has accumulated a thorough understanding of the industry, regulations, subsectors and the companies involved in this fast growing space.
14 14 W W W. V A L E N S G R O W O R K S. C O M L O C A T I O N 230 C A R I O N RD. K E L O W N A, B R I T I S H C O L U M B I A C A N A D A V 4 V 2 K 5 C O N T A C T U S E V E R E T V A L E N S G R O W O R K S. C O M ( 778) S C O T V A L E N S G R O W O R K S. C O M ( )
CSE: VGW OTC: VGWCF CORPORATE PRESENTATION APRIL 2019
CSE: VGW OTC: VGWCF CORPORATE PRESENTATION APRIL 2019 3 NOTICE TO RECIPIENT This investment is suitable only for sophisticated investors for whom an investment does not constitute a complete investment
More informationNurturing Shareholder Growth
JULY 2018 Nurturing Shareholder Growth EMBLEM CORP. TSXV: EMC DISCLAIMER This documentation is a presentation (the Presentation ) of general background information about Emblem Corp s., ( Emblem ) activities
More informationCORPORATE PRESENTATION CANADA S CANNABIS COMPANY
CORPORATE PRESENTATION CANADA S CANNABIS COMPANY LEGAL DISCLAIMER NOTICE TO RECIPIENT This investment is suitable only for sophisticated investors for whom an investment does not constitute a complete
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY. February 2019
DRIVING THE GLOBAL CANNABIS INDUSTRY February 2019 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable Canadian securities laws and forward-looking
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY
DRIVING THE GLOBAL CANNABIS INDUSTRY The 14 th Regional Investments & Capital Markets Conference of the Jamaica Stock Exchange January 2019 FORWARD-LOOKING STATEMENT This presentation contains forward-looking
More informationDISCLAIMER STATEMENTS
January 2019 DISCLAIMER STATEMENTS This presentation relates to an entity that is directly involved in the United States cannabis industry insofar as its business activities include the cultivation, production,
More informationTSX:LEAF Investor Presentation December 2017 Top Licensed Producer
TSX:LEAF Investor Presentation December 2017 Top Licensed Producer Price Close (Dec 7, 2017): $15.47 Market Capitalization: $1.5 billion Basic and F.D. Shares: 94.1/101.4 million Forward-Looking Information
More informationOverview September, 2018
Overview September, 2018 A preliminary prospectus (the Prospectus ) containing important information relating to the securities described in this document has been filed with the securities regulatory
More informationPresented by: Eric Paul & Brad Rogers
Improving the Quality of your Life Presented by: Eric Paul & Brad Rogers 1 A focused medical approach to meet the specific needs of the physicians and patients Standardized Products provide us the ability
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY. Bruce Linton Chairman, Founder & Co-CEO February 2019
DRIVING THE GLOBAL CANNABIS INDUSTRY Bruce Linton Chairman, Founder & Co-CEO February 2019 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable
More informationTSX:LEAF Investor Presentation March 2018
TSX:LEAF Investor Presentation March 2018 Price Close (Mar 16, 2018): $19.34 Market Capitalization: $1.9 billion Basic and F.D. Shares: 99.8/109.6 million Forward-Looking Information This Presentation
More informationINVESTOR PRESENTATION. June 01, 2018 CSE: CALI OTCQB: FNNZF
INVESTOR PRESENTATION June 01, 2018 CSE: CALI OTCQB: FNNZF DISCLAIMER Cautionary Note Regarding Forward-Looking Information These materials include forward-looking statements. Such statements are based
More informationInvestor Presentation August 23, 2017
Investor Presentation August 23, 2017 Forward-Looking Information This Presentation contains forward-looking information within the meaning of applicable Canadian securities legislation which are based
More informationTSX:LEAF Investor Presentation October 2017
TSX:LEAF Investor Presentation October 2017 Price Close (Oct 6, 2017): $9.80 Market Capitalization: $890 million Basic and F.D. Shares: 90.8/93.2 million Forward-Looking Information This Presentation contains
More informationInvestor Presentation. TSX Venture (OGI) OTCQX Best Market (OGRMF)
Investor Presentation TSX Venture (OGI) OTCQX Best Market (OGRMF) Disclaimer & Cautionary Statements This document is current as of February 8, 2019, except where otherwise stated. The information contained
More informationWe Have A Good Thing Growing
This documentation is a presentation (the Presentation ) of general background information about Aphria Inc. s ( Aphria ) activities current as of April 16, 2018, unless stated otherwise. It is information
More informationCorporate Presentation
Corporate Presentation April 2018 CSE: CRZ OTCQX: CNNRF INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated March 2018 (the Presentation ) contains forward-looking
More informationCORPORATE PRESENTATION
CORPORATE PRESENTATION November 2018 Delivering Long-term Success in Cannabis Investing CSE : CGOC cgocorp.com 1 Disclaimer Terms undefined herein have the meanings ascribed to them in the Prospectus.
More informationZenabis November 21, 2018
Zenabis November 21, 2018 Disclaimers IMPORTANT: YOU MUST READ THE FOLLOWING BEFORE CONTINUING. The information contained in this document has been prepared by Sun Pharm Investments Ltd. ( Sun Pharm or
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY. Bruce Linton Founder, Chairman & Co-CEO November 2018
DRIVING THE GLOBAL CANNABIS INDUSTRY Bruce Linton Founder, Chairman & Co-CEO November 2018 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable
More informationCSE:CRZ 1 OTCQX:CNNRF
CSE:CRZ OTCQX:CNNRF 1 INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated November 2017 (the Presentation ) contains forward-looking information regarding
More informationCorporate Presentation
Corporate Presentation March 2018 CSE: CRZ OTCQX: CNNRF 0 INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated March 2018 (the Presentation ) contains forward-looking
More informationDISCLAIMER STATEMENTS
November 2018 DISCLAIMER STATEMENTS This presentation relates to an entity that is directly involved in the United States cannabis industry insofar as its business activities include the cultivation, production,
More informationCORPORATE PRESENTATION
CORPORATE PRESENTATION OCTOBER 2018 CSE: CHM OTCQB: CHMJF FORWARD LOOKING STATEMENTS This corporate document contains forward-looking statements and forward-looking information (collectively, forward-looking
More informationPREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT
PREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT Q2 2018 Investor Presentation PREMIUM January MEDICAL CANNABIS 10, 2018 POWERED BY SUN DISCLAIMER This documentation is a presentation (the Presentation ) of
More informationDISCLAIMER LIBERTY HEALTH SCIENCES INC. I INVESTORS PRESENTATION 2
DISCLAIMER This documentation is a presentation (the Presentation ) of general background information about Liberty Health Sciences Inc. s ( Liberty Health Sciences ) activities current as of September
More informationOverview September, 2018
Overview September, 2018 A preliminary prospectus (the Prospectus ) containing important information relating to the securities described in this document has been filed with the securities regulatory
More informationIntroduction to Nature s Way Management Group Inc.
Introduction to Nature s Way Management Group Inc. (A majority controlled subsidiary of E-Debit Global Corporation WSHE OTC Markets ) Corporate Back Ground An Introduction to Nature s Way Management Group
More informationGlobal Leader in Medical Cannabis Created by Aphria & Nuuvera Combination. January 29, 2018
Global Leader in Medical Cannabis Created by Aphria & Nuuvera Combination January 29, 2018 Disclaimer This documentation is a presentation (the Presentation ) of general background information about Aphria
More informationInvestor Presentation
Investor Presentation 23 January 2019 2019 MMJ Group Holdings Limited ASX: MMJ www.mmjgh.com.au MMJ Group Holdings Limited Global cannabis investment company Corporate Details Portfolio Investment Approach
More informationQ INVESTOR PRESENTATION. A Global Cannabis Leader
Q4 2018 INVESTOR PRESENTATION A Global Cannabis Leader July 31, 2018 This documentation is a presentation (the Presentation ) of general background information about Aphria Inc. s ( Aphria ) activities
More informationPREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT
PREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT Q2 2018 Investor Presentation PREMIUM January MEDICAL CANNABIS 10, 2018 POWERED BY SUN DISCLAIMER This documentation is a presentation (the Presentation ) of
More information(TSXV: LABS) MEDIPHARM LABS CORP. MANAGEMENT S DISCUSSION AND ANALYSIS FOR THE YEAR ENDED DECEMBER 31, 2018
(TSXV: LABS) MEDIPHARM LABS CORP. FOR THE YEAR ENDED DECEMBER 31, 2018 April 3, 2019 This management s discussion and analysis ( MD&A ) of the financial condition and performance of (the Company ) was
More informationI n v e s t o r P r e s e n t a t i o n A c q u i s i t i o n o f C a n n a F a r m s
I n v e s t o r P r e s e n t a t i o n A c q u i s i t i o n o f C a n n a F a r m s July 30, 2018 TSX-V: VIVO OTCQB: ABCCF Disclaimer Certain information included in this presentation, which was prepared
More information( TEST TSX-V) Ultra Sensitive Cannabis Testing
( TEST TSX-V) Ultra Sensitive Cannabis Testing Disclaimer: Forward-Looking Information 2 This presentation contains "forward-looking information" within the meaning of applicable securities legislation.
More informationScythian Biosciences Makes Strategic Investment in Verano Holdings with $188 Million USD Transaction
Scythian Biosciences Makes Strategic Investment in Verano Holdings with $188 Million USD Transaction Scythian Invests USD$88 Million in Verano Class B Membership Units Scythian to Sell 3 Boys Farms in
More informationCannabis Insurance Application
Cannabis Insurance Application 1. Please answer all questions. If any section does not apply, please indicate with Not Applicable OR None. 2. If there is insufficient space to complete your answer for
More informationCorporate Presentation
Corporate Presentation APRIL 2018 OTCQB: AGTK 1 INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated April 2018 (the Presentation ) contains forward-looking
More informationBUILDING THE FIRST TRUE CANNABIS CPG PLATFORM DIXIE BRANDS INC. INVESTOR PRESENTATION Q CSE: DIXI.U
BUILDING THE FIRST TRUE CANNABIS CPG PLATFORM DIXIE BRANDS INC. INVESTOR PRESENTATION Q4 2018 CSE: DIXI.U!1 Forward-Looking Information Certain statements in this presentation may constitute "forward-looking"
More informationCanopy Growth to Acquire Hiku Brands to Strengthen Retail and Brand Portfolio
Canopy Growth to Acquire Hiku Brands to Strengthen Retail and Brand Portfolio July 10, 2018 SMITHS FALLS, ON & TORONTO Canopy Growth Corporation ( Canopy Growth ) (TSX:WEED) (NYSE:CGC) and Hiku Brands
More informationGolden Leaf Reports Fiscal First Quarter 2018 Results
Golden Leaf Reports Fiscal First Quarter 2018 Results Toronto, Ontario May 30, 2018 Golden Leaf Holdings Ltd. ( Golden Leaf or the Company ) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company
More informationLOON ENERGY CORPORATION AGREES TO AMALGAMATION WITH EMERGING CANNABIS COMPANY
LOON ENERGY CORPORATION AGREES TO AMALGAMATION WITH EMERGING CANNABIS COMPANY Calgary, Alberta: September 17, 2018 Loon Energy Corporation (NEX: LNE.H) ( Loon ) announces that it has entered into an Amalgamation
More informationHARVEST ENTERPRISES GROUP OF COMPANIES
HARVEST ENTERPRISES GROUP OF COMPANIES MANAGEMENT S DISCUSSION & ANALYSIS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018 AND 2017 (Expressed in United States dollars) MD&A of Harvest Enterprises Group
More informationInner Spirit Holdings
CSE:ISH Inner Spirit Holdings Corporate Presentation November 2018 LEGAL DISCLAIMER. The information provided herein is not intended to provide financial, tax, legal or accounting advice. This Corporate
More informationCannex - CSE: CNNX OTCQX: CNXXF. A Perfect Match.
Cannex - CSE: CNNX OTCQX: CNXXF & A Perfect Match. DISCLAIMER Cautionary Note Regarding Forward-Looking Information This investor presentation dated November 28, 2018 contains certain forward-looking information
More informationDisclaimer Aspen Aerogels
Investor Presentation January 2018 Disclaimer This presentation contains statements that constitute forward looking statements under the Private Securities Litigation Reform Act of 1995. All statements
More informationMarijuana Business Application
Marijuana Business Application Email Applications to: info@orangeinsurance.com APPLICANT S INSTRUCTIONS: 1. All Applicants must complete the relevant sections of this Application in accordance with the
More informationProspectus Phivida Company we us Agents forward-looking statements "U.S. Securities Act"
Prospective investors should rely only on the information contained in the final prospectus dated November, 2017 (the Prospectus ). This presentation is qualified in its entirety by reference to, and must
More informationEconomic, Repeatable and Environmentally Responsible
Economic, Repeatable and Environmentally Responsible Cameron Todd CEO US Oil Sands Inc. A presentation to the University of Utah Unconventional Fuels Conference May 15, 2012 Forward Looking Statements
More informationCANNABIS WHEATON INCOME CORP. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31, Stated in Canadian Funds
CANNABIS WHEATON INCOME CORP. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31, 2018 Stated in Canadian Funds DATE: MAY 30, 2018 For the Period Ended March 31, 2018
More informationSTRATEGIC PARTNERSHIP WITH ALTRIA TO ACCELERATE GROWTH AND INNOVATION
NASDAQ / TSX TICKER CRON STRATEGIC PARTNERSHIP WITH ALTRIA TO ACCELERATE GROWTH AND INNOVATION December 2018 Disclaimers & Cautionary Statements C R O N O S G R O U P INC. This communication contains forward-looking
More informationDISCLAIMER LIBERTY HEALTH SCIENCES INC. I INVESTORS PRESENTATION 2
DISCLAIMER This documentation is a presentation (the Presentation ) of general background information about Liberty Health Sciences Inc. s ( Liberty Health Sciences ) activities current as of July 7, 2017.
More informationRecreational Marijuana in Oregon How it Will Look Rob Patridge, Chair, Commission ODMO, December 2015
Recreational Marijuana in Oregon How it Will Look Rob Patridge, Chair, Commission ODMO, December 2015 ROLE OF COMMISSIONERS Guide policy Facilitate public engagement Support communication Adopt final rules
More informationAirBoss of America Corp. Investor Presentation
AirBoss of America Corp. Investor Presentation March 2019 1 AirBoss of America Corp. Forward Looking Information Certain statements contained or incorporated by reference herein, including those that express
More informationInvestor Presentation
Investor Presentation 31 August 2018 2018 MMJ PhytoTech Limited ASX: MMJ www.mmjphytotech.com.au MMJ Global cannabis investment company Listed on the ASX and trades with the code MMJ Circa 16,000 shareholders;
More informationEMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2017
EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2017 Dated: November 15, 2017 - 2 - TABLE OF CONTENTS Forward-Looking Statements...
More informationPreparing for Emissions Trading
Preparing for Emissions Trading Roon Osman Head of Asia Pacific Markets, Environmental Products, Shell 25 th September, Seoul September 2013 Disclaimer The companies in which Royal Dutch Shell plc directly
More informationStone Ridge Exploration Corp. Suite Howe Street Vancouver, B.C. V6C 2C2
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES Stone Ridge Exploration
More informationCorporate Presentation April 2017 CSE: CRZ OTCQB: CNNRF
Corporate Presentation April 2017 CSE: CRZ OTCQB: CNNRF INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated April 2017 (the Presentation ) contains forward-looking
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (State or other jurisdiction of incorporation) FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY. February 2018
DRIVING THE GLOBAL CANNABIS INDUSTRY February 2018 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable Canadian securities laws and forward-looking
More informationDISCLAIMER LIBERTY HEALTH SCIENCES INC. I INVESTORS PRESENTATION 2
DISCLAIMER This documentation is a presentation (the Presentation ) of general background information about Liberty Health Sciences Inc. s ( Liberty Health Sciences ) activities current as of September
More informationCorporate Presentation November 2017
Investing In High Yield Businesses Around The Globe Corporate Presentation November 2017 Disclaimer This presentation ( Presentation ) is provided on the basis that neither LGC Capital Ltd) (the Company
More informationThis presentation contains forward-looking information within the meaning of applicable Canadian securities legislation, including management s
August 9, 2016 2 This presentation contains forward-looking information within the meaning of applicable Canadian securities legislation, including management s expectations and certain assumptions with
More informationianthus Capital Acquires Medical Cannabis Business of GrowHealthy Holdings, Marking Full-Scale Entry into Fast Growing Florida Market
January 17, 2018 ianthus Capital Acquires Medical Cannabis Business of GrowHealthy Holdings, Marking Full-Scale Entry into Fast Growing Florida Market Company to Host a Conference Call at 4:20 PM ET on
More informationInvestor Presentation March 20, AirBoss of America Corp.
Investor Presentation March 20, 2017 1 AirBoss of America Corp. Forward Looking Statements Certain statements contained or incorporated by reference herein, including those that express management s expectations
More informationAGL Resources to be Acquired by Southern Company. August 24, 2015
AGL Resources to be Acquired by Southern Company August 24, 2015 Transaction Overview Southern Company to acquire AGL Resources for $66.00 per share in cash Premium of 36.3% to AGL Resources shareholders
More informationFORM 7 MONTHLY PROGRESS REPORT
FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: ALQ Gold Corp. (the Issuer ). Trading Symbol: ALQ Number of Outstanding Listed Securities: 56,033,658* * Please note this total includes 5,518,670
More informationImplementing Recreational Marijuana in Oregon
Implementing Recreational Marijuana in Oregon Marijuana Is Now and Will Still Be Illegal Unless consumed by an adult Unless consumed in a private residence Unless grown for personal use only or by an entity
More informationSmall-Cap Research. Ceapro Inc. (V.CZO - TSXV) SUMMARY DATAt ZACKS ESTIMATES
Small-Cap Research June 6, 2017 John D. Vandermosten, CFA 312-265-9588 / jvandermosten@zacks.com scr.zacks.com 10 S. Riverside Plaza, Suite 1600, Chicago, IL 60606 Ceapro Inc. (V.CZO - TSXV) In-line 4Q:17
More informationManagement s Discussion and Analysis
- 1 - Management s Discussion and Analysis For the Three and Nine Months Ended September 30, 2018 This Management s Discussion and Analysis ( MD&A ) is prepared as at November 29, 2018 and should be read
More informationMichigan Prevention Association
Michigan Prevention Association T h e S t a t e o f M a r i h u a n a i n t h e S t a t e o f M i c h i g a n : I n c l u d i n g a r e v i e w o f t h e N e w F a c i l i t i e s L a w s a n d P r o p
More informationZenectWealth.com Page 1
ZenectWealth.com Page 1 LEGAL DISCLAIMER The information in this report has been obtained from sources believed to be reliable. However, the accuracy of this information cannot be guaranteed. Examples
More information34 th Annual J.P. Morgan Healthcare Conference. Steve Collis, President & CEO Tim Guttman, EVP & CFO
34 th Annual J.P. Morgan Healthcare Conference Steve Collis, President & CEO Tim Guttman, EVP & CFO January 12, 2016 Steve Collis President & CEO Cautionary Note Regarding Forward-Looking Statements Certain
More informationCannabics Pharmaceuticals, Inc. Breakthrough Cannabis Medications - Review and Outlook.
Cannabics Pharmaceuticals, Inc. Breakthrough Cannabis Medications - Review and Outlook. Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX), is engaged in the development of Personalized Anti- Cancer treatments.
More informationCorporate Presentation March 2018
Rapidly Creating a Global Cannabis Supplier Corporate Presentation March 2018 Disclaimer This presentation ( Presentation ) is provided on the basis that neither LGC Capital Ltd. ( LGC ) nor its officers,
More informationPOCML 4 INC. Management s Discussion and Analysis. (a Capital Pool Corporation) For the Quarter Ended: March 31, Date of Report: May 30, 2018
POCML 4 INC. (a Capital Pool Corporation) Management s Discussion and Analysis For the Quarter Ended: March 31, 2018 Date of Report: May 30, 2018 This management s discussion and analysis of the financial
More informationIR PRESENTATION June 2018
IR PRESENTATION June 2018 FORWARD-LOOKING STATEMENTS Certain information contained in these materials and to be discussed during this presentation constitute forward-looking information within the meaning
More informationPrivate Capital Adapts to New American Energy Paradigm ALTERNATIVE LIQUIDITY OPTIONS. JW Marriott, Galleria
Private Capital Adapts to New American Energy Paradigm ALTERNATIVE LIQUIDITY OPTIONS JW Marriott, Galleria "Don't be afraid to give up the good to go for the great." ~ John D Rockefeller DISCLAIMER The
More informationCALIFORNIA CANNABIS TAX & PAYMENT GUIDE GUIDANCE FOR
CALIFORNIA CANNABIS TAX & PAYMENT GUIDE GUIDANCE FOR DISTRIBUTORS RETAILERS CULTIVATORS MANUFACTURERS Expert navigation of the complex tax and payment requirements of California s emerging cannabis market
More informationEMERALD HEALTH THERAPEUTICS, INC.
EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three and six months ended June 30, 2018 Dated: August 29, 2018-1 - TABLE OF CONTENTS Forward-Looking Statements... 3 Overview...
More informationTHE SUPREME CANNABIS COMPANY, INC. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS. For the three months ended September 30, 2018
THE SUPREME CANNABIS COMPANY, INC. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS For the three months ended September 30, 2018 Date: November 14, 2018 THE SUPREME CANNABIS COMPANY, INC. Management
More informationGLOBAL LEADER IN MEDICAL CANNABIS CREATED BY APHRIA AND NUUVERA COMBINATION
GLOBAL LEADER IN MEDICAL CANNABIS CREATED BY APHRIA AND NUUVERA COMBINATION Combination capitalizes on Nuuvera s expansive international footprint, expanding network into Europe, Africa and the Middle
More informationPRELIMINARY PROSPECTUS. Non-Offering Prospectus September 20, 2016 QUADRON CAPITAL CORPORATION
A copy of this preliminary prospectus has been filed with the securities regulatory authority in British Columbia but has not yet become final. Information contained in this preliminary prospectus may
More informationElixinol Global Limited
Elixinol Global Limited FY2017 Results Presentation For the year ending 31 December 2017 DRAFT 27 February 2018 Disclaimer This presentation contains summary information about Elixinol Group Limited (Elixinol)
More informationAnnual & Special Meeting of Shareholders
Annual & Special Meeting of Shareholders September 3 rd, 2015 Our only business is your business Agenda I. Introductions II. Business Portion of the Meeting III. President s Overview IV. Questions Introductions
More informationFourth Quarter Review of Financial Results. April 2, 2018
Fourth Quarter 2017 Review of Financial Results April 2, 2018 Forward-Looking Statements This Presentation has been prepared by Calumet Specialty Products Partners, L.P. (the Company or Calumet ) as of
More informationAmended and Restated. Marapharm Ventures Inc. Watch us grow!
Amended and Restated Marapharm Ventures Inc. Watch us grow! MANAGEMENT DISCUSSION & ANALYSIS For The Three Months Ended September 30, 2017 Introduction The following management discussion and analysis
More informationNovember 2013 Dr Alistair Fraser VP Health, Royal Dutch Shell
November 2013 VP Health, Royal Dutch Shell Copyright of Royal Dutch Shell November 2013 1 DEFINITIONS AND CAUTIONARY NOTE Reserves: Our use of the term reserves in this presentation means SEC proved oil
More informationIR PRESENTATION January 2019
IR PRESENTATION January 2019 FORWARD-LOOKING STATEMENTS Certain information contained in these materials and to be discussed during this presentation constitute forward-looking information within the meaning
More informationCanopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results: Gross Sales of $98M; Net Revenue hits record $83M
Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results: Gross Sales of $98M; Net Revenue hits record $83M Cannabis shipments totaled 10,102 kilograms and kilogram equivalents. Net
More informationTurner Valley Oil & Gas, Inc. Referred herein as the Company Turner Valley and Turner Valley Oil And Gas
1 ANNUAL REPORT OF Turner Valley Oil & Gas, Inc. Referred herein as the Company Turner Valley and Turner Valley Oil And Gas FOR THE YEAR ENDED December 31, 2017 A NEVADA CORPORATION Phone: 1-713-588-9453
More informationCONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND SIX MONTH PERIODS ENDED MAY 31, 2018
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED - PREPARED BY MANAGEMENT) (EXPRESSED IN CANADIAN DOLLARS) FOR THE THREE AND SIX MONTH PERIODS ENDED MAY 31, 2018 1 NOTICE OF NO AUDITOR REVIEW
More informationCRONOS GROUP INC. Management s Discussion and Analysis of Financial Condition and Results of Operations. For the First Quarter Ended March 31, 2018
CRONOS GROUP INC. Management s Discussion and Analysis of Financial Condition and Results of Operations For the First Quarter Ended March 31, 2018 (in thousands of Canadian dollars) GENERAL MATTERS This
More informationFor personal use only. annual general meeting
annual general meeting 2017 DISCLAIMER Summary information This Presentation contains summary information about Skin Elements Limited (ASX: SKN, Skin Elements, the Company ), its subsidiaries and their
More informationVILLAGE FARMS INTERNATIONAL REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS/PURE SUNFARMS EXPANDING CANNABIS PRODUCTION AND SALES
FOR IMMEDIATE RELEASE VILLAGE FARMS INTERNATIONAL REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS/PURE SUNFARMS EXPANDING CANNABIS PRODUCTION AND SALES NOT FOR DISTRIBUTION OVER UNITED STATES WIRE SERVICES
More informationLARGE OPEN HEAD STEEL DRUMS
Small and Medium Enterprises Business Opportunities LARGE OPEN HEAD STEEL DRUMS MANUFACTURING Small and Medium Enterprises Business Opportunities TECHNICAL FOCAL POINT: Saeful Sukardi Head of Waste Logistics
More informationC O R P O R A T E P R E S E N T A T I O N APRIL 2018 C$ RQB
C O R P O R A T E P R E S E N T A T I O N APRIL 2018 C$ RQB U$ RVVQF 1IT F O R W A R D L O O K I N G S T A T E M E N T This presentation contains forward-looking statements. These forward-looking statements
More informationInvestment for the Canadian Recreational Cannabis Market
CANOPY GROWTH CORPORATION REPORTS FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS: DRIVING READINESS FOR THE CANADIAN RECREATIONAL CANNABIS MARKET Total licensed footprint exceeding 2.4 million sq.
More informationCANOPY GROWTH CORPORATION
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (IN CANADIAN DOLLARS) TABLE OF CONTENTS Condensed interim consolidated statements of financial position... 1 Condensed interim consolidated
More information